1. Home
  2. EVAX vs JCSE Comparison

EVAX vs JCSE Comparison

Compare EVAX & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • JCSE
  • Stock Information
  • Founded
  • EVAX 2008
  • JCSE 1999
  • Country
  • EVAX Denmark
  • JCSE Singapore
  • Employees
  • EVAX N/A
  • JCSE N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • EVAX Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • EVAX 17.8M
  • JCSE 5.9M
  • IPO Year
  • EVAX 2021
  • JCSE 2022
  • Fundamental
  • Price
  • EVAX $2.94
  • JCSE $1.13
  • Analyst Decision
  • EVAX Strong Buy
  • JCSE
  • Analyst Count
  • EVAX 2
  • JCSE 0
  • Target Price
  • EVAX $10.00
  • JCSE N/A
  • AVG Volume (30 Days)
  • EVAX 71.6K
  • JCSE 206.2K
  • Earning Date
  • EVAX 10-30-2025
  • JCSE 10-29-2025
  • Dividend Yield
  • EVAX N/A
  • JCSE 8.04%
  • EPS Growth
  • EVAX N/A
  • JCSE N/A
  • EPS
  • EVAX N/A
  • JCSE 0.00
  • Revenue
  • EVAX $3,176,000.00
  • JCSE $14,126,397.00
  • Revenue This Year
  • EVAX N/A
  • JCSE N/A
  • Revenue Next Year
  • EVAX $425.50
  • JCSE N/A
  • P/E Ratio
  • EVAX N/A
  • JCSE $245.74
  • Revenue Growth
  • EVAX 1042.45
  • JCSE 6.92
  • 52 Week Low
  • EVAX $1.20
  • JCSE $0.86
  • 52 Week High
  • EVAX $17.20
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 52.53
  • JCSE 54.02
  • Support Level
  • EVAX $2.81
  • JCSE $1.02
  • Resistance Level
  • EVAX $3.04
  • JCSE $1.57
  • Average True Range (ATR)
  • EVAX 0.20
  • JCSE 0.14
  • MACD
  • EVAX -0.01
  • JCSE 0.01
  • Stochastic Oscillator
  • EVAX 71.19
  • JCSE 34.33

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: